At the news
? NEUTRALIMPACT 2/10 CLUSTER filed Apr 30, 2026 at 17:38 ET
Two C-suite insiders at Nurix Therapeutics sold a combined $107K in open-market shares on April 30, 2026, following derivative exercises at $0 cost. The sales are routine tax-related dispositions tied to option exercises and represent only ~0.006% of the $1.7B market cap, making them immaterial.
- Chief Scientific Officer Gwenn Hansen sold 3,214 shares at $16.65 for $53K on April 30, 2026
- Chief Legal Officer Christine Ring sold 3,214 shares at $16.65 for $53K on April 30, 2026
- Both insiders simultaneously exercised 2,000 options each at $0 exercise price (non-cash events)
- Total open-market sales of $107K represent ~0.006% of NRIX's $1.7B market cap
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access